Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients. Palanichamy A, Jahn S, Nickles D, Derstine M, Abounasr A, Hauser SL, Baranzini SE, Leppert D, von Büdingen H-C J Immunol. 2014 Jun 13. PMID: 24928997. Abstract CommentRecommendBookmarkWatch